K. Otani et al., CORRELATION BETWEEN STEADY-STATE PLASMA-CONCENTRATIONS OF MIANSERIN AND TRAZODONE IN DEPRESSED-PATIENTS, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 347-349
Objective: The correlations between steady-state plasma concentrations
of mianserin and its active metabolite desmethylmianserin and those o
f trazodone and its active metabolite m-chlorophenylpiperazine (m-CPP)
were examined in 19 depressed patients. Methods: Ten patients receive
d first mianserin (30 mg per day) and second trazodone (150 mg per day
), while 9 patients received these treatments in the opposite sequence
, with at least 2-week intervals between the two phases. Blood was sam
pled at steady state, 1-3 weeks after initiation of each treatment. Pl
asma concentrations of mianserin, the separate enantiomers S(+)- and R
(-)-mianserin, desmethylmianserin, trazodone and m-CPP were measured b
y means of high-performance liquid chromatography. Results: There was
a significant correlation between steady-state plasma concentrations o
f trazodone and total mianserin (r = 0.59) or S(+)-mianserin (r = 0.57
), but not R(-)-mianserin (r = 0.33). Conclusion: The present study th
us suggests that the metabolic capacity of mianserin, especially the m
ore active S(+)-enantiomer, and that of trazodone correlate to each ot
her. This finding supports the previous suggestions that cytochrome P4
502D6 is involved in the metabolism of mianserin and trazodone.